Chidamide is an orally active benzamide-class histone deacetylase (HDAC) inhibitor that selectively targets HDAC1, 2, 3, and 10 enzymes to treat various cancers, including peripheral T-cell lymphoma. This… Read more
Chidamide is an orally active benzamide-class histone deacetylase (HDAC) inhibitor that selectively targets HDAC1, 2, 3, and 10 enzymes to treat various cancers, including peripheral T-cell lymphoma. This category offers high-quality reference standards essential for pharmaceutical laboratories engaged in impurity profiling and rigorous quality control protocols. The collection includes the Chidamide active pharmaceutical ingredient (API), specific process-related and degradation impurities, and stable isotope-labelled compounds such as Chidamide-d4 and Chidamide-13C6. These stable isotope-labelled standards are indispensable internal standards for liquid chromatography-mass spectrometry (LC-MS) and other analytical testing methods, providing accurate quantification during method validation and stability studies. Researchers and analysts utilize these certified materials to ensure compliance with regulatory standards and to maintain the precision and reliability of pharmaceutical analysis throughout the drug development and manufacturing lifecycle.